Livaptan Intermediate
have 2 Relevant products
Livaptan (Vpa-985) Is A Phase Iii Drug Developed By Cardiokine Inc., Which Focuses On Cardiovascular Disease Treatment And Preventive Drug Development. As Of May 2010, Lixivaptan Was In Phase Iii Clinical Trials Involving Patients With Hyponatremia, Inclu
